Crispr Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $94M | 1.7M | 54.01 |
| 2024-03-31 | $112M | 1.6M | 68.16 |
| 2023-12-31 | $100M | 1.6M | 62.60 |
| 2023-09-30 | $70M | 1.5M | 45.39 |
| 2023-06-30 | $86M | 1.5M | 56.14 |
| 2023-03-31 | $67M | 1.5M | 45.23 |
| 2022-12-31 | $59M | 1.4M | 40.65 |
| 2022-06-30 | $80M | 1.3M | 60.77 |
| 2022-03-31 | $76M | 1.2M | 62.77 |
| 2021-09-30 | $40M | 361k | 111.93 |
| 2021-06-30 | $43M | 264k | 161.88 |
| 2021-03-31 | $32M | 260k | 121.84 |
| 2020-12-31 | $38M | 250k | 153.08 |
| 2020-09-30 | $33M | 390k | 83.64 |
| 2020-06-30 | $25M | 334k | 73.50 |
| 2020-03-31 | $7.9M | 186k | 42.41 |
| 2019-12-31 | $10M | 170k | 60.90 |
| 2019-09-30 | $3.4M | 82k | 41.05 |
| 2019-03-31 | $2.3M | 64k | 35.53 |
| 2018-12-31 | $1.7M | 60k | 28.87 |
| 2018-09-30 | $2.3M | 52k | 44.41 |
| 2018-06-30 | $2.9M | 49k | 58.48 |
| 2018-03-31 | $1.9M | 41k | 45.71 |
| 2017-12-31 | $405k | 17k | 23.45 |
| 2017-09-30 | $309k | 17k | 17.88 |
| 2017-06-30 | $273k | 17k | 16.04 |